These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33321517)

  • 1. Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic.
    O'Shea CJ; Thomas G; Middeldorp ME; Harper C; Elliott AD; Ray N; Lau DH; Campbell K; Sanders P
    Eur Heart J; 2021 Feb; 42(5):520-528. PubMed ID: 33321517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring.
    Galand V; Hwang E; Gandjbakhch E; Sebag F; Marijon E; Boveda S; Leclercq C; Defaye P; Rosier A; Martins RP
    Arch Cardiovasc Dis; 2021 May; 114(5):407-414. PubMed ID: 34088625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular arrhythmia burden in patients with implantable cardioverter defibrillator and remote patient monitoring during different time intervals of the COVID-19 pandemic.
    Hauck C; Schober A; Schober A; Fredersdorf S; Hubauer U; Maier L; Keyser A; Huttelmaier M; Fischer T; Jungbauer C; Ücer E
    Eur J Med Res; 2022 Nov; 27(1):234. PubMed ID: 36348435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation burden during the coronavirus disease 2019 pandemic.
    O'Shea CJ; Middeldorp ME; Thomas G; Harper C; Elliott AD; Ray N; Campbell K; Lau DH; Sanders P
    Europace; 2021 Sep; 23(9):1493-1501. PubMed ID: 34077513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the COVID-19 lockdown on the arrhythmic burden of patients with implantable cardioverter-defibrillators.
    Sassone B; Virzì S; Bertini M; Pasanisi G; Manzoli L; Myers J; Grazzi G; Muser D
    Pacing Clin Electrophysiol; 2021 Jun; 44(6):1033-1038. PubMed ID: 34022067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
    Kloppe A; Proclemer A; Arenal A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
    Circulation; 2014 Jul; 130(4):308-14. PubMed ID: 24838360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of life-threatening ventricular arrhythmias in implantable defibrillator patients after the World Trade Center attack.
    Steinberg JS; Arshad A; Kowalski M; Kukar A; Suma V; Vloka M; Ehlert F; Herweg B; Donnelly J; Philip J; Reed G; Rozanski A
    J Am Coll Cardiol; 2004 Sep; 44(6):1261-4. PubMed ID: 15364329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
    Raitt MH; Klein RC; Wyse DG; Wilkoff BL; Beckman K; Epstein AE; Coromilas J; Friedman PL; Martins J; Ledingham RB; Greene HL;
    Am J Cardiol; 2003 Apr; 91(7):812-6. PubMed ID: 12667566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Incidence of Ventricular Arrhythmias in Patients With Advanced Cancer and Implantable Cardioverter-Defibrillators.
    Enriquez A; Biagi J; Redfearn D; Boles U; Kamel D; Ali FS; Hopman WM; Michael KA; Simpson C; Abdollah H; Campbell D; Baranchuk A
    JACC Clin Electrophysiol; 2017 Jan; 3(1):50-56. PubMed ID: 29759695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I; Erath JW; Russo AM; Burch AE; Assmus B; Bonderman D; McNitt S; Kutyifa V
    Heart Rhythm; 2021 Mar; 18(3):404-410. PubMed ID: 33248269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention patients.
    Zhou Y; Zhao S; Chen K; Hua W; Su Y; Chen S; Liang Z; Xu W; Zhang S
    BMC Cardiovasc Disord; 2019 Oct; 19(1):230. PubMed ID: 31638918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of COVID-19 lockdown on arrhythmias in patients with implantable cardioverter-defibrillators in southern Italy.
    Ducceschi V; de Divitiis M; Bianchi V; Calvanese R; Covino G; Rapacciuolo A; Russo V; Canciello M; Volpicelli M; Ammirati G; Sangiuolo R; Papaccioli G; Ciardiello C; Innocenti S; D'Onofrio A
    J Arrhythm; 2022 Jun; 38(3):439-445. PubMed ID: 35785398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anger-induced T-wave alternans predicts future ventricular arrhythmias in patients with implantable cardioverter-defibrillators.
    Lampert R; Shusterman V; Burg M; McPherson C; Batsford W; Goldberg A; Soufer R
    J Am Coll Cardiol; 2009 Mar; 53(9):774-8. PubMed ID: 19245968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emotional and physical precipitants of ventricular arrhythmia.
    Lampert R; Joska T; Burg MM; Batsford WP; McPherson CA; Jain D
    Circulation; 2002 Oct; 106(14):1800-5. PubMed ID: 12356633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of ventricular arrhythmias related to COVID infection and vaccination in patients with Brugada syndrome: Insights from a large Italian multicenter registry based on continuous rhythm monitoring.
    Casella M; Conti S; Compagnucci P; Ribatti V; Narducci ML; Marcon L; Massara F; Valeri Y; De Francesco L; Martino AM; Ghiglieno C; Schiavone M; Balla C; Dell'Era G; Pelargonio G; Forleo GB; Iacopino S; Sgarito G; Calò L; Tondo C; Russo AD; Patti G
    J Cardiovasc Electrophysiol; 2023 Jun; 34(6):1386-1394. PubMed ID: 37194742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celivarone in patients with an implantable cardioverter-defibrillator: adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions.
    Gojkovic O; Aliot EM; Capucci A; Connolly SJ; Crijns H; Hohnloser SH; Kulakowski P; Roy D; Radzik D; Singh BN; Kowey PR
    Heart Rhythm; 2012 Feb; 9(2):217-224.e2. PubMed ID: 21978965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmia Risk During the 2016 US Presidential Election: The Cost of Stressful Politics.
    Rosman L; Salmoirago-Blotcher E; Mahmood R; Yang H; Li Q; Mazzella AJ; Lawrence Klein J; Bumgarner J; Gehi A
    J Am Heart Assoc; 2021 Jun; 10(11):e020559. PubMed ID: 34014121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of monitoring zones in the detection of arrhythmias in patients with implantable cardioverter-defibrillators under remote monitoring.
    Aguiar Rosa S; Silva Cunha P; Lousinha A; Valente B; Delgado AS; Pimenta R; Brás M; Coutinho Cruz M; Portugal G; Viveiros Monteiro A; Oliveira M; Cruz Ferreira R
    Rev Port Cardiol (Engl Ed); 2019 Jan; 38(1):11-16. PubMed ID: 30686652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).
    Guerra F; Palmisano P; Dell'Era G; Ziacchi M; Ammendola E; Bonelli P; Patani F; Cupido C; Devecchi C; Accogli M; Occhetta E; Santangelo L; Biffi M; Boriani G; Capucci A;
    Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.